Mutagenicity of CL 64 855, a potent anti-Trypanosoma cruzi drug
- 1 July 1986
- journal article
- research article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 171 (1) , 11-15
- https://doi.org/10.1016/0165-1218(86)90003-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agentsMemórias do Instituto Oswaldo Cruz, 1984
- Revised methods for the Salmonella mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1983
- Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparationsArchives of Biochemistry and Biophysics, 1982
- A nitroimidazole-thiadiazole derivative with curative action in experimentalTrypanosoma cruziinfectionsPathogens and Global Health, 1982
- Mechanism of nifurtimox toxicity in different forms of Trypanosoma cruziBiochemical Pharmacology, 1981
- Mutagenicity of nifurtimox in Escherichia coliMutation Research/Genetic Toxicology, 1980
- Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their useNature, 1976
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975
- 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole: A New Antimicrobial AgentScience, 1968